K to 7 Softgel Capsule is a combination supplement containing Calcitriol (0.25 mcg), Calcium Carbonate (1250 mg), and Vitamin K2-7 (45 mcg), formulated to support bone health and calcium metabolism. Calcitriol, the active form of vitamin D3, enhances intestinal absorption of calcium and phosphate, thereby promoting bone mineralization. Calcium Carbonate serves as a vital mineral supplement to maintain adequate calcium levels essential for bone strength and neuromuscular function. Vitamin K2-7 (menaquinone-7) plays a crucial role in activating osteocalcin, a protein responsible for binding calcium to the bone matrix, thus improving bone density and reducing the risk of fractures. This combination is particularly beneficial in conditions such as osteoporosis, osteomalacia, and hypocalcemia, where calcium and vitamin D metabolism is impaired. K to 7 Softgel Capsule is indicated for adults requiring supplementation to prevent or treat calcium deficiency and support skeletal integrity. The softgel formulation ensures better bioavailability and ease of administration. It is recommended to use this product under medical supervision, especially in patients with hypercalcemia, renal impairment, or those on concurrent medications affecting calcium metabolism. Regular monitoring of serum calcium and renal function is advised during prolonged therapy to avoid potential adverse effects.